- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/193 - Equine encephalomyelitis virus
Patent holdings for IPC class A61K 39/193
Total number of patents in this class: 49
10-year publication summary
|
2
|
2
|
3
|
6
|
2
|
1
|
0
|
2
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Intervet International B.V. | 1282 |
7 |
| Intervet Inc. | 871 |
6 |
| AlphaVax, Inc. | 26 |
4 |
| Boehringer Ingelheim Vetmedica, Inc. | 119 |
2 |
| Academia Sinica | 912 |
2 |
| Medigen, Inc. | 15 |
2 |
| The University of North Carolina at Chapel Hill | 1993 |
2 |
| Gritstone bio, Inc. | 113 |
2 |
| Merck Sharp & Dohme Corp. | 2219 |
1 |
| Centre National de La Recherche Scientifique | 10091 |
1 |
| Life Technologies Corporation | 3207 |
1 |
| President and Fellows of Harvard College | 5911 |
1 |
| The Trustees of the University of Pennsylvania | 4254 |
1 |
| Acambis Inc. | 2 |
1 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2062 |
1 |
| Her Majesty the Queen in Right of Canada, as represented by the Minister of National Defence | 213 |
1 |
| Imperial College Innovations Limited | 528 |
1 |
| Institut Pasteur | 789 |
1 |
| Lentigen Corporation | 7 |
1 |
| Sanofi Pasteur | 304 |
1 |
| Other owners | 10 |